Nestlé Health Science (NHSc) is a wholly-owned subsidiary of Nestlé S.A., headquartered in Vevey, Switzerland. Established as a strategic business unit within the world's largest food and beverage conglomerate, NHSc operates at the intersection of nutrition and healthcare, focusing on science-backed nutritional solutions. The company generated approximately 6.6 billion Swiss Francs (approximately $7.5 billion USD) in revenue in 2025, making it one of the fastest-growing business segments within the Nestlé group. NHSc commands a top-tier position in the global medical nutrition and premium dietary supplement markets.
Core Business
Nestlé Health Science develops and manufactures an extensive portfolio of nutritional products spanning medical nutrition, consumer wellness, and vitamins, minerals, and supplements (VMS). The company's medical nutrition division, anchored by flagship brands such as Peptamen and Isosource, provides specialized formula foods for patients with compromised gastrointestinal function and critical illness. These products serve hospitals, clinics, and homecare settings worldwide. In the consumer wellness segment, NHSc operates leading brands including Vital Proteins, the number-one collagen supplement brand, and Garden of Life, a prominent organic supplement line, both of which dominate health category rankings on major e-commerce platforms such as Amazon and Tmall. The company also invests heavily in precision nutrition, leveraging artificial intelligence to deliver personalized vitamin and supplement solutions, representing a significant strategic focus for 2025 and beyond.
Global Presence
Nestlé Health Science maintains a substantial global footprint with operations spanning over 150 countries, with particular strength in North America, Europe, and Asia. China represents its second-largest market globally, supported by localized manufacturing capabilities at the Taizhou facility in Jiangsu Province, which produces approximately 28,000 metric tons of specialized medical food annually. The company operates 15 wholly-owned manufacturing facilities worldwide, including dedicated organic production in Wisconsin, USA, high-care medical nutrition plants in Germany and Switzerland, and its flagship Asia-Pacific production base in China. NHSc employs approximately 10,000 professionals including research scientists, production staff, medical affairs specialists, and sales teams. Its global research and development infrastructure includes three major R&D centers located in Lausanne, Switzerland; Somerset, USA; and Beijing, China. Combined annual production capacity reaches approximately 1.8 billion units across liquid nutrition, specialty infant formulas, and capsule/tablet formats.
Key Strengths
Nestlé Health Science benefits from unmatched advantages derived from its parent company's scale, supply chain infrastructure, and brand credibility. The company's proprietary traceability system, fully upgraded in 2025, ensures 100% raw material traceability from farm to finished product for core ingredients such as whey protein and probiotic strains. This vertical integration, combined with world-class manufacturing standards and deep regulatory expertise across global markets, creates formidable barriers to entry. NHSc's portfolio spans the full spectrum from prescription medical foods to mainstream consumer wellness, enabling cross-selling opportunities and resilience across economic cycles. With a brand heat score of 965 out of 1,000 and sustained double-digit growth trajectory, Nestlé Health Science is positioned as the definitive leader in the convergence of nutrition science and healthcare.
